|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 316.80 CHF | -0.35% |
|
+2.16% | +23.99% |
| 07:30pm | US FDA approves Innoviva's oral antibiotic for gonorrhea | RE |
| 02:05pm | Natera and MEDSIR to Collaborate on the Mirador Trial in Breast Cancer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 342B | |||||
| 904B | |||||
| 506B | |||||
| 396B | |||||
| 283B | |||||
| 256B |
- Stock Market
- Equities
- ROG Stock
- Charts Roche Holding AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition